Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Johns

Showing results (341-350 of 355) with videos related to

Pageof 36
Sort By:
The Journal of Pathology|May 15, 2025
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterizationAntonio Pea, Michele Bevere, Anastasios Gkountakos, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vaterDavid K Chang, Nigel B Jamieson, Amber L Johns, et al.
Cell Reports|January 26, 2016
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationMarie-Claude Gingras, Kyle R Covington, David K Chang, et al.
Science Advances|September 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusKendelle J Murphy, Daniel A Reed, Claire Vennin, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Gastroenterology|November 19, 2016
Hypermutation In Pancreatic CancerJeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 36

Showing results (341-350 of 355) with videos related to

Sort By:
Pageof 36
The Journal of Pathology|May 15, 2025
Mucinous cystic neoplasms and simple mucinous cysts are two distinct precursors of pancreatic cancer: clinicopathological, genomic, and transcriptomic characterizationAntonio Pea, Michele Bevere, Anastasios Gkountakos, et al.
Annals of Surgery|July 18, 2020
Precision Oncology in Surgery: Patient Selection for Operable Pancreatic CancerStephan B Dreyer, Mark Pinese, Nigel B Jamieson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 27, 2013
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vaterDavid K Chang, Nigel B Jamieson, Amber L Johns, et al.
Cell Reports|January 26, 2016
Ampullary Cancers Harbor ELF3 Tumor Suppressor Gene Mutations and Exhibit Frequent WNT DysregulationMarie-Claude Gingras, Kyle R Covington, David K Chang, et al.
Science Advances|September 29, 2021
Intravital imaging technology guides FAK-mediated priming in pancreatic cancer precision medicine according to Merlin statusKendelle J Murphy, Daniel A Reed, Claire Vennin, et al.
Science Translational Medicine|April 7, 2017
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasisClaire Vennin, Venessa T Chin, Sean C Warren, et al.
Nature Cancer|August 28, 2023
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancerJessica L Chitty, Michelle Yam, Lara Perryman, et al.
Nature|February 27, 2015
Whole genomes redefine the mutational landscape of pancreatic cancerNicola Waddell, Marina Pajic, Ann-Marie Patch, et al.
Gastroenterology|November 19, 2016
Hypermutation In Pancreatic CancerJeremy L Humphris, Ann-Marie Patch, Katia Nones, et al.
Nature|September 28, 2017
Corrigendum: Whole-genome landscape of pancreatic neuroendocrine tumoursAldo Scarpa, David K Chang, Katia Nones, et al.
Pageof 36